Ontak-like human IL-2 fusion toxin
2017 · Journal of Immunological Methods · 41 citations
https://doi.org/10.1016/j.jim.2017.05.008
D
David H. Sachs
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
13
Papers
1.3K
Citations
11
h-index
11
i10-index
David H. Sachs is an academic researcher from NewYork–Presbyterian Hospital. The author has contributed to research in topics: Xenotransplantation and immune response & T-cell and B-cell Immunology & Animal Genetics and Reproduction. The author has an h-index of 11, co-authored 12 publications.
Papers by this author
worksDiphtheria‐toxin based anti‐human CCR4 immunotoxin for targeting human CCR4+ cells in vivo
2015 · Molecular Oncology · 38 citations
https://doi.org/10.1016/j.molonc.2015.04.004
Diphtheria toxin‐based anti‐human <scp>CD</scp>19 immunotoxin for targeting human <scp>CD</scp>19<sup>+</sup> tumors
2017 · Molecular Oncology · 23 citations
https://doi.org/10.1002/1878-0261.12056
Dosing optimization of <scp>CCR</scp>4 immunotoxin for improved depletion of <scp>CCR</scp>4<sup>+</sup> Treg in nonhuman primates
2018 · Molecular Oncology · 10 citations
https://doi.org/10.1002/1878-0261.12331
Porcine Treg depletion with a novel diphtheria toxin-based anti-human CCR4 immunotoxin
2016 · Veterinary Immunology and Immunopathology · 10 citations
https://doi.org/10.1016/j.vetimm.2016.10.014
CONTENT ALERTS
2014 · 0 citations
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat